Aortic Aneurysm Stent Grafts - Market Insights, Competitive Landscape, and Market Forecast - 2030

Aortic Aneurysm Stent Grafts Market By Product (Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft), By End-User (Hospitals, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2027 owing to increasing cases of an aortic aneurysm and rising regulatory approvals
Global Aortic Aneurysm Stent Grafts Market growing at a CAGR of 5.71% during the forecast period from 2022 to 2027. The Aortic Aneurysm Stent Grafts market is witnessing positive growth owing to the increasing cases of patients suffering from aortic aneurysm and the growing aging population, rising regulatory approvals, rapid technological developmental activities. Further, an increase in the prevalence of cardiac diseases and growing awareness of these devices is thereby contributing to the growth of the Aortic Aneurysm Stent Grafts market during the forecast period from 2022-2027.

Aortic Aneurysm Stent Grafts Devices Market Dynamics:

The Aortic Aneurysm Stent Grafts market is witnessing a growth in product demand owing to various reasons. The key factor includes the increasing cases of an aortic aneurysm globally, which leads to more demand for the product, thereby creating growth opportunities for the Global Aortic Aneurysm Stent Grafts Market.

There are several risk factors such as smoking and alcohol consumption, which are very crucial in the development of aortic aneurysms.

As per CDC 2021, a history of smoking accounts for about 75% of all abdominal aortic aneurysms. The U.S. Preventive Services Task Force recommends that men 65 to 75 years old who have ever smoked should get an ultrasound screening for abdominal aortic aneurysms, even if they have no symptoms. In fact, the abdominal aortic aneurysms prevalence is four times higher in smokers than in non-smokers. Hence, early detection is essential for treatment because survival is dependent on the pathway of the disease. This is responsible for the growth of the Global Aortic Aneurysm Stent Grafts Devices market, thereby contributing to the growth of the overall Aortic Aneurysm Stent Grafts Devices market during the forecast period from 2022-2027.

Another key factor responsible for the growth of the Aortic Aneurysm Stent Grafts Devices market is the increasing geriatric population base across the globe. According to the data provided by the World Health Organization, in 2020, about one billion people across the world were over the age of 60. The source further stated that by 2050, the elderly population in the 60 and above age group is expected to double in number representing about 2.1 billion people, and people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million. Age is considered as one of the key risk factors associated with the development of various cardiac disorders such as aortic aneurysm, therefore, the rising elderly population is expected to lead to a rise in the patient population of diseases across the world, which in turn would lead to an increase in demand for Aortic Aneurysm Stent Grafts Devices in the forecast period (2022-2027), which will drive the Aortic Aneurysm Stent Grafts Devices market growth.

However, high costs of the treatment and perioperative and postoperative complications like the risk of stent movement and many others may be certain limiting factors of the Aortic Aneurysm Stent Grafts Devices market growth.

The Aortic Aneurysm Stent Grafts Devices market was one of the few markets that reported positive growth during the COVID-19 pandemic. The impact of the COVID-19 pandemic resulted in the surge in revenue for the Aortic Aneurysm Stent Grafts Devices market due to the growing demand among COVID-19-patients. Therefore, the market for Aortic Aneurysm Stent Grafts Devices was expected to witness a positive growth rate during the COVID-19 pandemic.

Aortic Aneurysm Stent Grafts Devices Market Segment Analysis:

Aortic Aneurysm Stent Grafts Devices Market By Product (Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft), By End-User (Hospitals, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Product segment of the Aortic Aneurysm Stent Grafts Devices market, the Abdominal Aortic Stent Graft is estimated to hold a higher share in the Aortic Aneurysm Stent Grafts Devices market during the forecast period (2022-2027). This can be attributed to the specific features associated with these devices.

The dominance of this segment is owing to the fact that abdominal stent graft therapy is a minimally invasive surgical procedure because it is not necessary to perform open-chest surgery or remove parts of the aorta.

Moreover, the rising research and development activities in the product arena and launch of these devices will also contribute to the growth of the Aortic Aneurysm Stent Grafts Devices market. For instance, on April 08, 2019, Shanghai MicroPort Endovascular MedTech Co., Ltd. obtained a registration certificate for its independently developed Minos™ Ultra-Low Profile Abdominal Aortic Aneurysm Stent Graft System from NMPA China.

Furthermore, abdominal aortic aneurysms (AAA) treatment with Abdominal Aortic Stent Graft has gained progressive acceptance owing to better perioperative outcomes than open aortic repair (OAR).

Therefore, considering the advantages associated with Abdominal Aortic Stent Graft, this product category is expected to generate significant revenue share eventually contributing to the overall growth of the global Aortic Aneurysm Stent Grafts Devices market during the forecast period.

North America is expected to dominate the overall Aortic Aneurysm Stent Grafts Devices Market:

Among all the regions, North America is expected to account for the largest share in the Global Aortic Aneurysm Stent Grafts Devices market. Factors such as the rising cases of aortic aneurysms, regulatory approvals, technical improvements, strong financial incentives, are expected to aid in the growth of the North America Aortic Aneurysm Stent Grafts Devices Market during the forecast period of 2022-2027.

The cases of aortic aneurysms are rising constantly in North America. These cases promote the need for use of Aortic Aneurysm Stent Grafts in disease treatments. For instance, as per CDC 2021, aortic aneurysms or aortic dissections were the cause of 9,904 deaths in 2019. In 2019, about 59% of deaths due to aortic aneurysm or aortic dissection occurred among menin United States.

Another factor responsible for the growth of the Aortic Aneurysm Stent Grafts Devices market is the rising regulatory product approvals of innovative devices. For instance, on May 11, 2021, Endologix LLC had announced the launch and first implant of its ALTO® Abdominal Stent Graft in Canada following recent approval from Health Canada.

In May 2020, Terumo Aortic announced the US Food and Drug Administration (FDA) approval of the TREO™ Abdominal Aortic Stent-Graft System for sale in the United States for the treatment of patients with abdominal aortic aneurysms (AAA).

These kinds of product launches in the local markets may drive the product demand in the market. The rising adoption of Aortic Aneurysm Stent Grafts Devices in the country would result in the rising demand for treatments that make use of Aortic Aneurysm Stent Grafts, which in turn would provide a conducive growth environment for the United States Aortic Aneurysm Stent Grafts Devices market as well as the North American region. Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as the new product launches in the region is expected to boost the North America Aortic Aneurysm Stent Grafts Devices market during the forecast period.

Aortic Aneurysm Stent Grafts Devices Market Key Players:

Some of the key market players operating in the Aortic Aneurysm Stent Grafts Devices market include Medtronic, Terumo, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (MicroPort Scientific Corporation), Cook, Cordis, JOTEC GmbH, W. L. Gore & Associates, Inc., Endologix LLC, Lombard Medical, Lifetech Scientific, SB-Kawasumi Laboratories, Inc., Endospan, and others.

Recent Developmental Activities in the Aortic Aneurysm Stent Grafts Devices Market:

• On August 18, 2020, Endospan had received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to start the TRIOMPHE study on the NEXUS Aortic Arch Stent Graft System.
• In September 2019, cardiac and vascular surgery company CyroLife Inc. signed a distribution agreement, credit facilities, and option agreement to acquire Israel-based stent-graft company EndoSpan Ltd. EndoSpan develops stent graft systems for treating aneurysms and dissections throughout the aorta.

Key Takeaways from the Aortic Aneurysm Stent Grafts Devices Market Report Study

• Market size analysis for current Aortic Aneurysm Stent Grafts Devices market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Aortic Aneurysm Stent Grafts Devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global Aortic Aneurysm Stent Grafts Devices market.
• Various opportunities available for the other competitor in the Aortic Aneurysm Stent Grafts Devices market space.
• What are the top performing segments in 2021? How these segments will perform in 2027.
• Which is the top-performing regions and countries in the current Aortic Aneurysm Stent Grafts Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Aortic Aneurysm Stent Grafts Devices market growth in the coming future?

Target Audience who can be benefited from this Aortic Aneurysm Stent Grafts Devices Market Report Study

• Aortic Aneurysm Stent Grafts Devices products providers
• Research organizations and consulting companies
• Aortic Aneurysm Stent Grafts Devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Aortic Aneurysm Stent Grafts Devices
• Various End-users who want to know more about the Aortic Aneurysm Stent Grafts Devices market and latest technological developments in the Aortic Aneurysm Stent Grafts Devices market.

Frequently Asked Questions for Aortic Aneurysm Stent Grafts Devices Market:

1. What are Aortic Aneurysm Stent Grafts Devices?
Aortic Aneurysm Stent Grafts are devices placed inside the abdominal aorta or thoracic aorta to help protect the aneurysm from rupturing. The stent graft is placed inside the aneurysm with the help of a long, very thin, soft, plastic tube called a delivery catheter.

2. What is the market for Global Aortic Aneurysm Stent Grafts Devices?
Global Aortic Aneurysm Stent Grafts Market growing at a CAGR of 5.71% during the forecast period from 2022 to 2027.

3. What are the drivers for Global Aortic Aneurysm Stent Grafts Devices Market?
The Aortic Aneurysm Stent Grafts Devices market is witnessing a positive market growth owing to the increasing cases of an aortic aneurysm and the growing aging population, rising regulatory approvals, rapid technological developmental activities. Further, an increase in the prevalence of cardiac diseases due to smoking and alcohol consumption and growing awareness of these devices is thereby contributing to the growth of the Aortic Aneurysm Stent Grafts market.

4. Who are the key players operating in the Global Aortic Aneurysm Stent Grafts Devices Market?
Some of the key market players operating in the Aortic Aneurysm Stent Grafts Devices market include Medtronic, Terumo, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (MicroPort Scientific Corporation), Cook, Cordis, JOTEC GmbH, W. L. Gore & Associates, Inc., Endologix LLC, Lombard Medical, Lifetech Scientific, SB-Kawasumi Laboratories, Inc., Endospan, and others.

5. Which region has the highest share in Aortic Aneurysm Stent Grafts Devices Market?
North America is expected to hold the highest share in the revenue in the Aortic Aneurysm Stent Grafts Devices market during the forecast period. Factors such as the rising cases of aortic aneurysms, regulatory approvals, technical improvements, strong financial incentives, are expected to aid in the growth of the North America Aortic Aneurysm Stent Grafts Devices Market in this region.


This product will be delivered within 2 business days.